Principal Investigators on treatment protocols that involve an Investigational New Drug (IND) must complete Form FDA 1572, which the sponsor then submits to FDA. Form FDA 1572 is the contract between ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Right now they’re evaluating 5 different investigational drugs for squamous cell lung cancer in the same protocol. And the plan is that over time, more investigational agents can be brought into ...

A type 1 diabetes patient talked about her successful treatment with an investigational stem cell ... single-dose vials are available for self-pay through LillyDirect, significantly expanding ...

These new vials are priced at least 50% lower than ... all thanks to the treatment potential of its investigational GLP-1 ...

A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committee (SRC) reviewed the data from ...

Remdac is priced at ₹2,800 per 100 mg vial, making it the cheapest version ... Inc to manufacture and sell Remdesivir, the investigational drug, which has been issued an emergency use ...

The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration. In a paper ...

The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for MF-300, a first-in-class orally administered, 15-hydroxyprostaglandin ...

Contact sponsor for Investigational Drug return Remove Investigational Drug and records from CRC pharmacy room Provide accountability records to sponsor Clinical research pharmacist meet with sponsor ...

An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...